Emerging Roles of Adaptive Immune Response in Alzheimer's Disease
aging and disease · 2024
DOI: 10.14336/ad.2024.0564 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift aging and disease, 2024. Verfasst von Cong Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Adaptive Immunity. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD) is the most common neurodegenerative disease and is characterized by progressive cognitive decline. Pathologically, this disease is associated with the accumulation of extracellular amyloid plaques, intracellular neurofibrillary tangles (NFTs), and neuroinflammation. Current drug treatments primarily focus on managing symptoms rather than stopping disease progression. Disease-modifying therapies target the clearance of amyloid plaques through active and passive immunity methods. Although successful in animal models, human trials have shown adverse effects, such as meningoencephalitis, in a small number of patients who received active immunity methods. The efficacy of active immunity methods in treating AD remains uncertain, but passive immunity methods amyloid-beta (Abeta)-specific monoclonal antibody therapies such as aducanumab and lecanemab have been approved by the FDA. Despite the limitations of immune-based therapies, T-cell, and chimeric antigen receptor-based treatments show promise, but new guidelines are necessary to address potential adverse events. Research into the relationship between adaptive immune responses and AD is expected to provide innovative treatment approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China.
- Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
- Department of Neurology, the Second Affiliated Hospital of Shandong First Medical University, Shandong First Medical University & Shandong Academy of Medical Sciences, Taian, China.
- Department of Neurology, the Third Affiliated Clinical Hospital of the Changchun University of Chinese Medicine, Changchun, China.
Zitieren
APA
Li, C., Zhao, Q., Feng, L., & Li, M. (2024). Emerging Roles of Adaptive Immune Response in Alzheimer's Disease. aging and disease. https://doi.org/10.14336/ad.2024.0564
Vancouver
Li C, Zhao Q, Feng L, Li M. Emerging Roles of Adaptive Immune Response in Alzheimer's Disease. aging and disease. 2024. doi:10.14336/ad.2024.0564
BibTeX
@article{Li2024,
author = {Li, Cong and Zhao, Qinghe and Feng, Lina and Li, Mingquan},
title = {Emerging Roles of Adaptive Immune Response in Alzheimer's Disease},
journal = {aging and disease},
year = {2024},
doi = {10.14336/ad.2024.0564}
}
EUVIMED